Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia

Published:2020-08-12 Issue:11 Volume:95 Page:1288-1295
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Abaza Yasmin¹^ORCID,Kantarjian Hagop¹^ORCID,Alwash Yasmin¹,Borthakur Gautam¹^ORCID,Champlin Richard²,Kadia Tapan¹^ORCID,Garcia‐Manero Guillermo¹,Daver Naval¹^ORCID,Ravandi Farhad¹,Verstovsek Srdan¹,Burger Jan¹,Estrov Zeev¹,Ohanian Maro¹^ORCID,Lim Miranda¹,Pemmaraju Naveen¹^ORCID,Jabbour Elias¹^ORCID,Cortes Jorge¹³^ORCID

Affiliation:

1. Department of Leukemia The University of Texas MD Anderson Cancer Center Houston Texas

2. Department of Stem Cell Transplant The University of Texas MD Anderson Cancer Center Houston Texas

3. Georgia Cancer Center Augusta University Augusta Georgia

Funder

Bristol-Myers Squibb

University of Texas MD Anderson Cancer Center

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.25939

Reference45 articles.

1. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

2. Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance

3. Current and emerging treatment options in chronic myeloid leukemia

4. Medical Management of CML

5. Optimizing Treatment of Chronic Myeloid Leukemia: A Rational Approach

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring;American Journal of Hematology;2024-08-02

2. Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma;Cell Reports Medicine;2024-04

3. Clinical Insights into Structure, Regulation, and Targeting of ABL Kinases in Human Leukemia;International Journal of Molecular Sciences;2024-03-14

4. Accelerated-phase CML: de novo and transformed;Hematology;2023-12-08

5. Chronic Myeloid Leukemia: Advance Phases of the Disease;Cancer Consult;2023-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3